Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/33631
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGrigg, Andrew P-
dc.contributor.authorPrabahran, Ashvind-
dc.contributor.authorDonati, Vanessa-
dc.contributor.authorWong, Eric-
dc.contributor.authorMason, Kate-
dc.date.accessioned2023-08-30T07:48:20Z-
dc.date.available2023-08-30T07:48:20Z-
dc.date.issued2023-08-
dc.identifier.citationInternal Medicine Journal 2023-08; 53(8)en_US
dc.identifier.issn1445-5994-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/33631-
dc.description.abstractSafe outpatient management of acute leukaemia consolidation cycles may enable substantial savings in admission costs. Safety involves the prompt administration of antibiotics in patients with neutropenic fever. Our unit in a metropolitan tertiary referral hospital analysed a cohort of patients spanning a 10-year period, with two key observations: (i) a high proportion of patients living a substantial distance from hospital and (ii) the high incidence and generally prompt onset of fever after severe neutropenia, suggesting this broad applicability of this approach is unfeasible without addressing travel issues and potentially reducing and/or delaying neutropenic fever with prophylactic antibiotics.en_US
dc.language.isoeng-
dc.subjectacute myeloid leukaemiaen_US
dc.subjectconsolidation chemotherapyen_US
dc.subjectneutropenic feveren_US
dc.subjectoutpatienten_US
dc.titleOutcome of an elective readmission policy in patients receiving acute myeloid leukaemia consolidation therapy and implications for an outpatient management programme.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleInternal Medicine Journalen_US
dc.identifier.affiliationClinical Haematologyen_US
dc.identifier.doi10.1111/imj.16193en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0001-6915-7442en_US
dc.identifier.pubmedid37599226-
dc.description.volume53-
dc.description.issue8-
dc.description.startpage1492-
dc.description.endpage1496-
dc.subject.meshtermssecondaryLeukemia, Myeloid, Acute/drug therapy-
dc.subject.meshtermssecondaryNeutropenia/chemically induced-
dc.subject.meshtermssecondaryNeutropenia/epidemiology-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.languageiso639-1en-
item.grantfulltextnone-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
crisitem.author.deptClinical Haematology-
crisitem.author.deptClinical Haematology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

14
checked on Feb 27, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.